Menu Search
Equities

Charmacy Pharmaceutical Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
2289:HKG.HS

Charmacy Pharmaceutical Co Ltd

Actions
  • Price (HKD)5.80
  • Today's Change0.00 / 0.00%
  • Shares traded6.00k
  • 1 Year change-29.27%
  • Beta-0.1872
Data delayed at least 15 minutes, as of Jan 30 2026 07:55 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Charmacy Pharmaceutical Co Ltd is a China-based company principally engaged in the distribution of pharmaceutical products. The Company mainly distributes western medicine, Chinese patent medicine and healthcare products to downstream distributors and retail terminals, while conducting dealings in the third-party logistics business of medicines and providing pharmaceutical products related consulting services. The Company's businesses cover the entire supply chain for pharmaceutical distribution, including procurement, sales, warehousing, transportation and delivery. The Company primarily operates its businesses in the domestic market.

  • Revenue in HKD (TTM)4.81bn
  • Net income in HKD54.68m
  • Incorporated1984
  • Employees849.00
  • Location
    Charmacy Pharmaceutical Co LtdNo. 235Song Shan North Road, Longhu DistrictSHANTOU 515041ChinaCHN
  • Phone+86 75 488206420
  • Fax+86 75 482752026
  • Websitehttps://www.chmyy.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.